최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓癌韓醫學會誌 = Journal of Korean traditional oncology, v.25 no.2, 2020년, pp.37 - 49
윤지현 (강동경희대학교한방병원 한방암센터 한방내과) , 김은혜 (강동경희대학교한방병원 한방암센터 한방내과) , 이지영 (강동경희대학교한방병원 한방암센터 한방내과) , 윤성우 (강동경희대학교한방병원 한방암센터 한방내과)
Objective: Constipation is the most common adverse effect of opioid analgesic therapy in cancer patients. This can be associated with physical and emotional distress to cancer patients. The purpose of this study is to review the standard and alternative interventions of the management for opioid-ind...
Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin 21(10):1555-1566, 2005
McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. Management of opioid side effects in cancer-related and chronic noncancer pain-A systematic review. J Pain 4(5):231-256, 2003
Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician 11(2):S105-S120, 2008
Hong KS, Jung KW, Lee TH, Lee BE, Park SY, Shin JE, Kim SE, Park KS, Choi SC. Current issudes on the treatment of chronic constipation. Korean J Gastroentero 64(3):148-153, 2014
Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017
Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017
Larkin PJ, Cherny NI, La Carpia D, et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(4):111-125, 2018
Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag 5(3):137-144. 2009
Gatti A, Sabato AF. Management of Opioid-Induced Constipation in Cancer Patients. Clin Drug Investig 32:293-301, 2012
LoCasale RJ, Datto CJ, Margolis MK, Tack J, Coyne KS. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use. Int J Clin Pract. 69(12):1448-1456, 2015
Jeon HH, Park HJ. Diagnosis and treatment of constipation. Korean J Med 83(5):568-579, 2012
Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 44(8):1201-1209, 2001
Agra Y, Sacristan A, Gonzalez M, Ferrari M, Portugues A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage 15(1):1-7, 1998
Ahmedzai, SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid 2010:2407, 2010
Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 11(4):575-581, 2008
Pitlick M, Fritz D. Evidence about the pharmacological management of constipation, part 2: implications for palliative care. Home Healthc Nurse 31(4):207-218, 2013
Selby W, Corte C. Managing constipation in adults. Aust Prescr 33:116-119, 2010
Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 43(2):306-313, 2012
Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Zuurmond WWA. The management of constipation in pallative care: Clinical practice recommendations. Palliat Med 22(7):796-807, 2008
National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 1. Fort Washington, PA: National Comprehensive Cancer Network; c2020. 2020 for Pallative care [cited 2020 Oct 19]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf
Siemens W, Becker G. Methylnaltrexone for opioid-induced constipation : Review and meta-analyses for objective plus subjective efficacy and safety outcomes. Ther Clin Risk Manag 12:401-412, 2016
Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 35(5):458-468, 2008
Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid induced constipation in advanced illness. N Engl J Med 358(22):2332-2343, 2008
Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 7(1):39-46, 2009
Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension. J Palliat Med 18(7):593-600, 2015
Mori M, Yongli J, Kumar S, Ashikaga T, Ades S. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study. Int J Clin Oncol 22:397-404, 2017
Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain 154(9):1542-1550, 2013
Chey WD, Webster L, Sostek M, Lappalainen J, Barkder PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 370:2387-2396, 2014
Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, Suzuki Y, Narabayashi M, Boku N. Phase IIb, randomized, double blind, placebo-controlled study of naldemedine for the treatment of opioid induced constipation in patients with cancer. J Clin Oncol 35:1921-1928, 2017
Clemens KE, Quednau I, Klaschik E. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. Int J Clin Pract 65:472-478, 2011
Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain 21:1528-1537, 2017
Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study. Eur J Pain 21:1485-1494, 2017
Chung VC, Wu X, Lu P, Hui EP, Zhang Y, Zhang AL, Lau AY, Zhao J, Fan M, Ziea ET, Ng BF, Wong SY, Wu JC. Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis. Medicine (Baltimore) 95(7):e2793, 2016. doi: 10.1097/MD.0000000000002793.
Gao YL, Li LY, Li PW. Clinical study on the effectiveness of Yi-Qi-Run-Chang Method for opioids induced constipation. J Trad Chin Med Emergency 19(4);585-586, 2016
Chen CM, Lin LZ, Zhang EX. Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin J Integr Med 20(7):496-502, 2014
Zhang FL, Lin HS, He QY. Effect of electro-acupuncture in treating morphine sulfate caused constipation in tumor patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29(10):922-925, 2009
Zhu HD, Gong Z, Hu BW, Wei QL, Kong J, Peng CB. The efficacy and safety of transcutaneous acupoint interferential current stimulation for cancer pain patients with opioid-induced constipation: A prospective randomized controlled study. Integr Cancer Ther 17(2):437-443, 2018
Cai H, Zhou Q, Bao G, Kong X, Gong LY. Transcutaneous electrical nerve stimulation of acupuncture points enhances therapeutic effects of oral lactulose solution on opioid-induced constipation. J Int Med Res 47(12):6337-6348, 2019
Markland AD, Palsson O, Goode PS, Burgio KL, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 108(5):796-803, 2013
Yang J, Wang HP, Zhou L, Xu CF. Effect of dietary fiber on constipation: A meta analysis. World J Gastroenterol 18(48):7378-7383, 2012
Lamas K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C. Effects of abdominal massage in management of constipation-a randomized controlled trial. Int J Nurs Stud 46(6):759-767, 2009
Park JU, Byun JI, Jung SH, Son IJ, Lee HS. Prophylactic laxative use and the compliance in relation to opioid-induced constipation. J Kor Soc Health-Syst Pharm 28(2):136-141, 2011
Wickham RJ. Managing Constipation in Adults With Cancer. J Adv Pract Oncol 8(2):149161, 2017
Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ. Methylnaltrexone treatment of opioid-induced constipation in patients with advanved illness. J Pain Symptom Manage 38(5):683-690, 2009
Cho NH, Ryu BH. A study on Constipation. Korean J Orient Int Med 21(1):169-180, 2000
Oh SD, Lim SM, Shin HS, Baek ET, Kim YT, Ra SY. The clinical review of bowel disorders following Parkinson's disease. Korean J Orient Int Med 22(4):735-742, 2001
Kang YL, Kim YJ, Hwang CW. The clinical study on 45 cases of patients of constipation caused by C.V.A who were treated with Bo-Riu Enema. Korean J Orient Int Med 21(2):329-336, 2000
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.